News & Events
BD To Present At Merrill Lynch Global Pharmaceutical, Medical Device & Biotechnology Conference
|
Contact: Camilla Jenkins/Media Relations - 201-847-5369 Dean Paranicas/Investor Relations - 201-847-7102 Franklin Lakes, NJ (February 01, 2001) -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today it will participate in the Merrill Lynch Global Pharmaceutical, Medical Device & Biotechnology Conference to be held at the Grand Hyatt Hotel in New York City. The BD presentation will be made on February 7, 2001 (1:35 p.m. Eastern Time).
The conference, including the BD presentation, will be webcast live. The web link will be made available later this week and will be publicized on the BD website, www.bd.com. The BD presentation can be accessed for replay on the BD website until 5:00 p.m. Eastern Time, February 13, 2001.
BD is a medical technology company that manufactures and sells a broad range of supplies, devices and systems for use by healthcare professionals, medical research institutions, industry and the general public. For the fiscal year ended September 30, 2000, BD reported total revenues of $3.6 billion.
|